Last reviewed · How we verify
Prevention of Transplant Rejection
Approved treatments
- Prograf · Astellas Pharma
Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell. - prednison · Wen Zhang
- Deltasone · Generic (originally Schering)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Transplant Rejection patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Transplant Rejection treatment landscape brief
- Prevention of Transplant Rejection treatment updates RSS
Frequently asked questions about Prevention of Transplant Rejection
What drugs treat Prevention of Transplant Rejection?
Tracked treatments include Prograf, prednison, Deltasone.
What is the treatment for Prevention of Transplant Rejection?
Standard treatment for Prevention of Transplant Rejection includes Prograf, prednison, Deltasone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Transplant Rejection patent cliff · Prevention of Transplant Rejection CI report
- Treatment: Prograf · Astellas Pharma
- Treatment: prednison · Wen Zhang
- Treatment: Deltasone · Generic (originally Schering)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing